Bacteria have been gradually evolving to become resistant to the antibiotics used to treat them. Over the last few years, scientists have found evidence that some bacteria have become resistant to a last resort antibiotic called colistin.
Researchers, including those from Imperial College London in the UK, tested 134 different colonies of bacteria using a machine called a mass spectrometer that is used to analyse various different molecules.
They studied bacteria called Escherichia coli and Klebsiella pneumonia.
Some strains of these bacteria have become resistant to nearly all available antibiotics mostly by producing antibiotic inactivating enzymes, researchers said.
This means that colistin often remains the only treatment option for these multidrug resistant bacteria. Unfortunately, some have now also developed resistance to colistin.
Researchers found that it was possible to distinguish not only between those bacteria that are colistin resistant, and those that are not, but also which bacteria have the more dangerous plasmid-encoded resistance.
"This means that it could be rolled out quickly and cheaply, and potentially have a rapid impact on tackling drug-resistance," Maumus said.
The test can be carried out in around 15 minutes and would cost less than one USD one per sample, researchers said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
